SPL.AX - Starpharma Holdings Limited

ASX - ASX Delayed Price. Currency in AUD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue4,9573,6474,5741,697
Cost of Revenue----
Gross Profit4,9573,6474,5741,697
Operating Expenses
Research Development10,57614,87521,41916,250
Selling General and Administrative4,6663,9894,4454,392
Non Recurring----
Total Operating Expenses15,24218,86425,86420,642
Operating Income or Loss-10,285-15,217-21,290-18,945
Income from Continuing Operations
Total Other Income/Expenses Net---2-5
Earnings Before Interest and Taxes-10,285-15,217-21,290-18,945
Interest Expense---2-5
Income Before Tax-10,285-15,217-21,292-18,950
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-10,285-15,217-21,292-18,950
Non-recurring Events
Discontinued Operations-23,417-1,383-1,383
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,2858,200-22,675-18,950
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,2858,200-22,675-18,950